BindingDB logo
myBDB logout

49 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26638043 66 Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor.EBI Universit£ degli Studi di Firenze
24164628 186 Adenosine A2A receptor as a drug discovery target.EBI Merck Research Laboratories
22468757 171 Medicinal chemistry of A3 adenosine receptor modulators: pharmacological activities and therapeutic implications.EBI Universit£ di Ferrara
21664729 142 Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.EBI Jagiellonian University Medical College
22486652 44 Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening.EBI National Institute of Diabetes and Digestive and Kidney Diseases
20188574 141 2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.EBI University of Bonn
19569717 251 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.EBI Institute
18424135 131 Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.EBI National Institute of Diabetes and Digestive and Kidney Diseases
18255292 35 Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-N,N-dialkyluronamides as human A3 adenosine receptor antagonists.EBI Ewha Womans University
15990306 4 BCUT descriptors to predicting affinity toward A3 adenosine receptors.EBI Experimental Sugar Cane Station"Villa Clara-Cienfuegos"
12930138 1 N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.EBI Ewha Womans University
11881988 16 Ribose-modified nucleosides as ligands for adenosine receptors: synthesis, conformational analysis, and biological evaluation of 1'-C-methyl adenosine analogues.EBI Universit£ di Camerino
12238926 99 Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.EBI National Institute of Diabetes and Digestive and Kidney Diseases
11708915 52 Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides.EBI National Institute of Diabetes and Digestive and Kidney Diseases
11170630 46 Nucleosides and nucleotides. 200. Reinvestigation of 5'-N-ethylcarboxamidoadenosine derivatives: structure-activity relationships for P(3) purinoceptor-like proteins.EBI Hokkaido University
10956189 98 A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives.EBI Universit£ di Pisa
10841798 64 Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.EBI National Institute of Diabetes
10212124 26 5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.EBI Leiden University
9703464 40 Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.EBI National Institute of Diabetes
9703463 102 Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists.EBI Universit£ di Ferrara
9667957 5 Nucleosides and nucleotides. 177. 9-(6,7-dideoxy-beta-D-allo-hept-5- ynofuranosyl)adenine: a selective and potent ligand for P3 purinoceptor-like protein.EBI Hokkaido University
9572897 49 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.EBI Universit£ di Camerino
8576924 69 Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors.EBI Universit£ di Ferrara
8709132 92 Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.EBI National Institute of Diabetes
7707320 99 Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.EBI National Institute of Diabetes
7752196 103 Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.EBI National Institute of Diabetes
8126704 79 Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.EBI National Institute of Diabetes
7966162 39 Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.EBI National Institute of Diabetes
7932588 48 2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.EBI National Institute of Diabetes
12617898 13 Design, synthesis and binding affinity of 3'-fluoro analogues of Cl-IB-MECA as adenosine A3 receptor ligands.EBI Seoul National University
9873707 12 Fluorescent probes for adenosine receptors: synthesis and biology of N6-dansylaminoalkyl-substituted NECA derivatives.EBI GlaxoWellcome Medicines Research Center
19879151 58 Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.EBI Ewha Womans University
19499950 64 Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.EBI National Institute of Diabetes and Digestive and Kidney Diseases
19375920 30 Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.EBI Ewha Womans University
18811138 41 Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.EBI Ewha Womans University
17149867 51 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.EBI Ghent University
16366590 12 Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.EBI National Institute of Diabetes and Digestive and Kidney Diseases
16356715 32 A topological function based on spectral moments for predicting affinity toward A3 adenosine receptors.EBI Vigo University
16289820 14 Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety.EBI National Institute of Diabetes and Digestive and Kidney Diseases
15771421 96 (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.EBI National Institute of Diabetes and Digestive and Kidney Diseases
12166930 21 Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist.EBI TBA
11087559 7 Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography.EBI University of Milano-Bicocca
10737749 182 Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.EBI National Institute of Diabetes
10052977 82 Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.EBI National Institute of Diabetes
9258367 99 Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.EBI National Institute of Diabetes
8863790 55 Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.EBI National Institute of Diabetes
8691424 61 Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.EBI National Institute of Diabetes
8558508 55 Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists.EBI National Institute of Diabetes
7932565 92 Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.EBI National Institute of Diabetes